|
|
||||||||
1 From the Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan; the 2 Department of Ophthalmology, Kinki University School of Medicine, Osaka, Japan; the 3 Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan; and the 4 Department of Ophthalmology, Nagoya University Graduate School of Medicine, Aichi, Japan.
| Abstract |
|---|
|
|
|---|
METHODS. Serum was obtained from 10 unrelated Japanese patients with STGD and 96 unrelated Japanese patients with autosomal recessive retinitis pigmentosa (arRP). All 50 ABCA4 gene exons of the patients with STGD were screened for mutations by a combination of single-strand conformation polymorphism analysis and polymerase chain reaction (PCR) direct-sequencing techniques. By restriction enzyme digestion, primer extension analysis, and PCR direct sequencing techniques, the patients with arRP were screened for three segregated, presumably null ABCA4 gene mutations observed in Japanese patients with STGD.
RESULTS. Three novel, presumably null mutations of the ABCA4 gene, IVS7-45_952delinsTCTGACC, IVS12+2T
G, and 1894delA, were identified. The Arg2149stop mutation that had been found in a white patient with STGD in a prior study was also found in a Japanese patient. Two arRP-affected siblings and two unrelated patients with STGD were found to be homozygous for the same IVS12+2T
G mutation, and three other arRP-affected siblings were carriers of the IVS12+2T
G mutation and/or the IVS7-45_952delinsTCTGACC mutation. These three siblings with arRP showed only atrophic degeneration in the macula early after the onset of the disease, and STGD had been diagnosed.
CONCLUSIONS. Three novel ABCA4 gene mutations were identified in Japanese patients with STGD and arRP. Mutations in the ABCA4 gene can cause panretinal degeneration that changes its clinical appearance from STGD to arRP over time.
| Introduction |
|---|
|
|
|---|
To our knowledge, there are no reports regarding mutations in the ABCA4 gene in Japanese patients with STGD. In this study, we screened Japanese patients with STGD for ABCA4 gene mutations and analyzed the association between the mutations and clinical phenotype.
| Methods |
|---|
|
|
|---|
Mutation Detection
All 50 exons of the ABCA4 gene were screened for mutations by a combination of single-strand conformation polymorphism (SSCP) analysis and polymerase chain reaction (PCR) direct-sequencing techniques.19
20
Genomic DNA was isolated from peripheral blood leukocytes by using a DNA extraction kit (DNA Micro Extraction Kit; Stratagene, La Jolla, CA) and amplified under standard conditions. Amplified exons were analyzed by electrophoresis on gels containing 6% polyacrylamide and 10% glycerol at 8 W for 16 hours at 4°C, and electrophoresis on gels containing 6% polyacrylamide at 12 W for 4 hours at 4°C. After electrophoresis, gels were stained with green fluorescent dye (SYBR Green Nucleic Acid Gel Stain; BioWhittaker Molecular Applications, Rockland, ME) and analyzed by laser-scanning image analyzer (FMBIO II Multi-View; Hitachi, Yokohama, Japan). PCR products that demonstrated band shifts on SSCP analysis were sequenced with a ready reaction kit (BigDye Terminator Cycle FS Ready Reaction Kit; PE-Applied Biosystems, Foster City, CA) and analyzed on an automated sequencer (Prism 3100 Gene Analyzer; PE-Applied Biosystems).
Screening of 96 normal control subjects for 17 sequence variations, cosegregation analyses of two STGD-affected families and two arRP-affected families, and screening of 96 Japanese patients with arRP for three segregated, presumably null mutations observed in Japanese patients with STGD were performed by restriction digestion, primer extension analysis, and direct sequencing.21
Because the IVS7-45_952delinsTCTGACC mutation causes a 139-bp deletion, the PCR products were analyzed by electrophoresis on a 2% agarose gel. The IVS12+2T
G mutation creates a FokI (TaKaRa, Tokyo, Japan) recognition site (5'-GGATG(N)9-3'); the Ile604Ser mutation a PvuII (TaKaRa) recognition site (5'-CAGCTG-3'); the 1894delA mutation a XhoII (TaKaRa) recognition site (5'-RGATCY-3'); the Glu1122Asp mutation a Hin1I (TaKaRa) recognition site (5'-GRCGYC-3'); and the Leu1583Pro mutation an EcoRII (TaKaRa) recognition site (5'-CCWGG-3'). All digested PCR products were analyzed by electrophoresis on an agarose gel. The other sequence variations were analyzed by primer extension analysis (SNaPshot Multiplex Kit; PE-Applied Biosystems) with an automated sequencer (Prism 3100 Gene Analyzer; PE-Applied Biosystems).
| Results |
|---|
|
|
|---|
G, IVS12-50G
A, Ile604Ser, 1894delA, Glu1122Asp, Leu1583Pro, Gly1623Ser, IVS38-36delT, Met1882Val, Arg2149stop, and Phe2188Ser sequence variations were not found in the 192 normal control alleles. Two STGD-affected families, F9 and F22, and two arRP-affected families, F1 and F26, participated in segregation analysis, and correct segregation of the disease alleles was demonstrated in these families (Fig. 1) . The IVS12+2T
G mutation was found in members of these STGD- and arRP-affected families, all of whom were homozygotes or compound heterozygotes. The IVS7-45_952delinsTCTGACC, IVS12+2T
G, and 1894delA mutations all segregated with the diseases (Fig. 2) .
|
|
|
G mutation, had RPE degeneration in the macula extending to the vascular arcades (Fig. 3B)
. ERGs obtained early in the course of the disease in these two patients were subnormal. At 11 years of age, patient F18-II-1 was found to have roughly one third of normal scotopic function and one half of normal photopic function (Fig. 4)
. Two siblings (F22-II-1 and F22-II-3), who were compound heterozygotes with the IVS12+2T
G and 1894delA mutations were observed to have posterior pole pigmentation. Three arRP siblings (F1-III-4, F1-III-6, and F1-III-8), all carriers of the IVS12+2T
G mutation and/or the IVS7-45_952delinsTCTGACC mutation were observed to have bone spiculelike pigmentation, severe RPE degeneration, and attenuated retinal vessels extending into the periphery with almost complete loss of both photopic and scotopic ERG amplitudes (Figs. 3E
4)
. Two arRP siblings (F26-II-4 and F26-II-6), homozygotes for the IVS12+2T
G mutation, were found to have severe RPE atrophy, bone spiculelike pigmentation, and attenuated retinal vessels in all areas of the retina and atrophic optic disc, with almost complete loss of both photopic and scotopic ERG amplitudes (Figs. 3C
4)
. The visual acuity of these patients with arRP was restricted to hand motions, with normal function remaining only in peripheral islands of the visual fields.
|
|
|
| Discussion |
|---|
|
|
|---|
G, Ile604Ser, 1894delA Glu1122Asp, Leu1583Pro, Gly1623Ser, Met1882Val, Arg2149stop, and Phe2188Ser sequence variations were not found in the 192 normal control alleles tested, and hence these are likely to be pathogenic mutations. The IVS7-45_952delinsTCTGACC, IVS12+2T
G, and 1894delA mutations segregated with the diseases in this study, and the Arg2149stop mutation has been reported to segregate with STGD.15
The Arg2149stop mutation found in a white patient with STGD in that study was also found in a Japanese patient in the current study. The other mutations found in European and North American patients with STGD were not found in Japanese patients with STGD. Some major polymorphisms found in European and North American individuals (Leu1894Leu, Leu1938Leu, IVS41-11G
A, Pro1948Pro, and Asp2095Asp) were also found in the Japanese population. Two rare sequence variations (IVS12-50G
A and IVS38-36delT) were also detected. The effects of these variations are unknown. The P1948P polymorphism, which has been reported in a study on Japanese patients with AMD, was observed in Japanese patients with STGD.24
25
Other sequence variations found in Japanese patients with AMD were not found in Japanese patients with STGD. ABCA4 gene mutations that have been studied as possible markers for AMD in European and North American individuals were not found in the Japanese patients with STGD, and the patients with STGD had no siblings that had been diagnosed with AMD.26
27
28
29
Previous studies have shown that most patients with STGD are compound heterozygous for two missense mutations or one null mutation and one missense mutation.4
11
12
13
14
15
16
17
18
In contrast, homozygotes with null mutations have arRP, arCRD, or severe STGD.6
7
8
9
10
11
12
13
14
15
16
The ABCA4 protein is present on the disc membrane of both cone and rod photoreceptor cells and has two ATP-binding domains, NBD1 and NBD2, which are important ATP sites.30
31
32
33
Mutations that cause arRP alter NBD1 and/or NBD2, resulting in ABCA4 proteins that are predicted to have no activity. Therefore, it is reasonable to assume that homozygotes or compound heterozygotes with null mutations in the ABCA4 gene would have reduced activity of the ABCA4 protein, leading to progressive degeneration of both cone and rod photoreceptors and resulting in the clinical features of arRP. In this study, all three families with STGD found to be homozygous or compound heterozygous for presumably null mutations had severe phenotypes (Table 2)
. These findings prompted us to screen 96 unrelated Japanese patients with arRP for the three segregated, presumably null mutations, IVS12+2T
G, 1894delA, and Arg2149stop. Two arRP-affected siblings (F26-II-4 and F26-II-5) were homozygous for the IVS12+2T
G mutation and two arRP-affected siblings (F1-III-4 and F1-III-6) were heterozygous for the IVS12+2T
G mutation. Screening of family F1 was performed with PCR direct sequencing, and family members were found to be carriers of the IVS12+2T
G mutation and/or the IVS7-45_952delinsTCTGACC mutation (Fig. 1)
.
As shown in Fig 3E , a patient from family F1 (F1-III-8) showed features of RP (night blindness, severe RPE atrophy, bone spiculelike pigmentation and attenuated retinal vessels in all areas of the retina) with an almost complete loss of scotopic ERG amplitude (Fig. 4) . However, when this patient was first examined in another hospital at 8 years of age, she showed only macular degeneration, and STGD was diagnosed (Fig. 3D) . These findings suggest that the clinical phenotype of this patient changed from STGD to arRP more than 20 years later. The clinical courses of patients F1-III-4 and F1-III-6 were similar to that of patient F1-III-8.
This study clearly showed that patient F26-II-6 (arRP, 41 years old) and patient F9-II-2 (STGD, 11 years old) shared the same ABCA4 gene mutation, IVS12+2T
G (Figs. 3B
3C)
. Furthermore, when patient F26-II-6 was first examined in our hospital in the fifth decade of life, we were informed that her initial symptoms were decreased visual acuity and night blindness in the first decade of life. In another hospital, patient F26-II-6 was found to have macular degeneration during childhood and exhibited progressive central scotoma to the periphery. At present, her visual acuity is restricted to hand motions, with only peripheral islands remaining functional in her visual fields. The clinical history of patient F26-II-6 supports the idea that the fundus appearance in members of family F26 early after onset may have resembled that of STGD, because patients from family F26 with arRP were homozygous for the IVS12+2T
G mutation, similar to the two patients with STGD analyzed (F9-II-2 [Fig. 3B
] and F18-II-1 [fundus photograph not shown]).
We speculate that null ABCA4 gene mutations can cause recessive panretinal degenerations such as central arRP, rather than typical arRP, in which retinal degeneration progresses from the periphery toward the macula.34 Furthermore, mutations in the ABCA4 gene can cause panretinal degeneration that changes its clinical appearance from STGD to arRP over time. Our study suggests that STGD and arRP, both resulting from ABCA4 gene mutations, may represent differing degrees of severity of the same disease. This idea is consistent with previous reports describing different phenotypic variations resulting from ABCA4 gene mutations and reports on the classification of STGD, in which patients (Gass classification Group III) showed atrophic maculopathy with late signs and symptoms of RP.5 6 7 8 9 10 11 12 13 35
In summary, we identified three novel ABCA4 gene mutations in Japanese patients with STGD and arRP. Mutations in the ABCA4 gene can cause panretinal degeneration that changes its clinical appearance from STGD to arRP over time.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication October 1, 2001; revised March 25, 2002; accepted April 29, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Shuji Yamamoto, Department of Ophthalmology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan; yamamoto{at}ophthal.med.osaka-u.ac.jp.
| References |
|---|
|
|
|---|
C mutation in the ABCR gene is a mild frequent founder mutation in Western European population and allows the classification of ABCR mutation in patient with Stargardt disease Am J Hum Genet 64,1024-1035[Medline][Order article via Infotrieve]
This article has been cited by other articles:
![]() |
A. V. Cideciyan, M. Swider, T. S. Aleman, Y. Tsybovsky, S. B. Schwartz, E. A.M. Windsor, A. J. Roman, A. Sumaroka, J. D. Steinberg, S. G. Jacobson, et al. ABCA4 disease progression and a proposed strategy for gene therapy Hum. Mol. Genet., March 1, 2009; 18(5): 931 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hargitai, J. Zernant, G. M. Somfai, R. Vamos, A. Farkas, G. Salacz, and R. Allikmets Correlation of Clinical and Genetic Findings in Hungarian Patients with Stargardt Disease Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4402 - 4408. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wiszniewski, C. M. Zaremba, A. N. Yatsenko, M. Jamrich, T. G. Wensel, R. A. Lewis, and J. R. Lupski ABCA4 mutations causing mislocalization are found frequently in patients with severe retinal dystrophies Hum. Mol. Genet., October 1, 2005; 14(19): 2769 - 2778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yokokura, Y. Wada, S. Nakai, H. Sato, R. Yao, H. Yamanaka, S. Ito, Y. Sagara, M. Takahashi, Y. Nakamura, et al. Targeted Disruption of FSCN2 Gene Induces Retinopathy in Mice Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2905 - 2915. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. September, A. A. Vorster, R. S. Ramesar, and L. J. Greenberg Mutation Spectrum and Founder Chromosomes for the ABCA4 Gene in South African Patients with Stargardt Disease Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1705 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wada, T. Abe, T. Itabashi, H. Sato, M. Kawamura, and M. Tamai Autosomal Dominant Macular Degeneration Associated With 208delG Mutation in the FSCN2 Gene Arch Ophthalmol, November 1, 2003; 121(11): 1613 - 1620. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |